Medlinker raises $147m as China's healthcare field widens

Tencent-backed startup secures new funding round and eyes M&A deals, as well as tapping artificial intelligence and big data.

It's no secret that investors are desperate to grab a slice of China's vastly promising healthcare sector a point underlined by an Rmb1 billion $147 million funding round for Tencent-backed Medlinker.

The size of the series-D round marks a big step forward for the four-year-old company, which had report just $100 million in earlier funding.

Like other startups in the healthcare sector, Medlinker is planning to use its funding to tap the latest technology, particularly the emerging areas of artificial intelligence and big data, to improve China's underdeveloped healthcare sector. Intriguingly, the company also said in its announcement on its official WeChat page that it planned...

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team subscription (2-5 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222